References
- MYKim, SKBaik, SSLee. Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol 2010;16:347–52.
- JWJang. Current status of liver diseases in Korea: liver cirrhosis. Korean J Hepatol 2009;15:S40–9.
- PTandon, GGarcia-Tsao. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008;28:26–42.
- LChristou, GPappas, MEFalagas. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol 2007;102:1510–17.
- SGhassemi, GGarcia-Tsao. Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol 2007;21:77–93.
- ARBonnel, CBunchorntavakul, KRReddy. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol 2011;9:727–38.
- SPascual, JSuch, AEsteban, PZapater, JACasellas, JRAparicio, et al. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003;50:1482–6.
- GGarcia-Tsao, RWiest. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 2004;18:353–72.
- HQSun, JYZhang, HZhang, ZSZou, FSWang, JHJia. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat 2012;19:396–403.
- FMeng, KWang, TAoyama, SIGrivennikov, YPaik, DScholten, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012;143:765–76; e1–3.
- JLi, SJQiu, WMShe, FPWang, HGao, LLi, et al. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS One 2012;7:e39307.
- NChalasani, GSmallwood, JHalcomb, MWFried, TDBoyer. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl Surg 1998;4:128–32.
- TMMcCashland, LCPreheim, MJGentry. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis 2000;181:757–60.
- ASMehta, RELong, MAComunale, MWang, LRodemich, et al. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J Virol 2008;82:1259–70.
- MPapp, GLNorman, ZVitalis, ITornai, IAltorjay, IFoldi, et al. Presence of anti-microbial antibodies in liver cirrhosis–a tell-tale sign of compromised immunity? PLoS One 2010;5:e12957.
- HDoi, TKIyer, ECarpenter, HLi, KMChang, RHVonderheide, et al. Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population. Hepatology 2012;55:709–19.
- RWiest, GGarcia-Tsao. Bacterial translocation (BT) in cirrhosis. Hepatology 2005;41:422–33.
- PBellot, RFrances, JSuch. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int 2013;33:31–9.
- SMoir, JHo, AMalaspina, WWang, ACDiPoto, MAO'Shea, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008;205:1797–805.
- JMBrenchley, DAPrice, TWSchacker, TEAsher, GSilvestri, SRao, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365–71.
- YShi, KAgematsu, HDOchs, KSugane. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin Immunol 2003;108:128–37.
- RCheruvattath, VBalan. Infections in patients with end-stage liver disease. J Clin Gastroenterol 2007;41:403–11.
- PABlair, LYNoreña, FFlores-Borja, DJRawlings, DAIsenberg, MREhrenstein, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010;32:129–40.
- CMauri, MREhrenstein. The 'short' history of regulatory B cells. Trends Immunol 2008;29:34–40.
- MRafei, JHsieh, SZehntner, MLi, KForner, EBirman, et al. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat Med 2009;15:1038–45.
- DJDiLillo, TMatsushita, TFTedder. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 2010;1183:38–57.
- ADas, GEllis, CPallant, ARLopes, PKhanna, DPeppa, et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012;189:3925–35.
- KItoh, SHirohata. The role of IL-10 in human B cell activation, proliferation, and differentiation. J Immunol 1995;154:4341–50.
- SKuchen, RRobbins, GPSims, CSheng, TMPhillips, PELipsky, et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol 2007;179:5886–96.
- NCaccamo, MTodaro, MPLa Manna, GSireci, GStassi, FDieli. IL-21 regulates the differentiation of a human gammadelta T cell subset equipped with B cell helper activity. PLoS One 2012;7:e41940.
- MALinterman, LBeaton, DYu, RRRamiscal, MSrivastava, JJHogan, et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med 2010;207:353–63.